Cormark Analysts Cut Earnings Estimates for Ascend Wellness

Ascend Wellness Holdings, Inc. (OTC:AAWH) – Stock analysts at Cormark reduced their FY2025 earnings per share (EPS) estimates for shares of Ascend Wellness in a research report issued on Wednesday, November 12th. Cormark analyst J. Pytlak now forecasts that the company will post earnings of ($0.46) per share for the year, down from their previous forecast of ($0.44). The consensus estimate for Ascend Wellness’ current full-year earnings is ($0.40) per share.

Separately, Zacks Research upgraded shares of Ascend Wellness from a “strong sell” rating to a “hold” rating in a research note on Monday, October 13th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat, the stock presently has an average rating of “Hold”.

Ascend Wellness Trading Down 4.8%

Shares of Ascend Wellness stock traded down $0.03 during mid-day trading on Friday, hitting $0.60. The stock had a trading volume of 54,588 shares, compared to its average volume of 168,782. Ascend Wellness has a 12-month low of $0.26 and a 12-month high of $0.98. The firm has a 50-day moving average of $0.75 and a two-hundred day moving average of $0.54. The firm has a market cap of $122.67 million, a P/E ratio of -1.46 and a beta of 1.12. The company has a quick ratio of 0.80, a current ratio of 1.47 and a debt-to-equity ratio of 2.61.

Ascend Wellness Company Profile

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.